Early Rehabilitation in Patients on Extracorporeal Membrane Oxygenation

Last updated: December 5, 2024
Sponsor: Australian and New Zealand Intensive Care Research Centre
Overall Status: Active - Not Recruiting

Phase

N/A

Condition

N/A

Treatment

Early Rehabilitation

Clinical Study ID

NCT05003609
ANZIC-RC/ECMO-REHAB/001
  • Ages > 18
  • All Genders

Study Summary

Critically ill patients who require extracorporeal membrane oxygenation (ECMO) are the sickest in the hospital. More patients are surviving but survivors have compromised functional recovery for months or years. This registry-embedded randomised trial aims to determine if early rehabilitation commenced within 72 hours of ECMO is feasible and improves muscle strength and functional status in patients compared to standard practice in a randomised controlled trial of 100 ICU patients. The effect of the intervention on mortality, health status, and function at 180 days will be evaluated, as well as cost-effectiveness. ECMO-Rehab trial is a registry embedded trial and will be utilising EXCEL data.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  1. Patient is on ECMO and expected to remain on ECMO for at least 24 hours

  2. Patient is aged 18 years or older.

  3. Patient was functionally independent prior to the current admission.

  4. Patient is eligible for Medicare (Australian sites only).

Exclusion

Exclusion Criteria:

  1. Patient has been receiving ECMO for more than 72 hours.

  2. Patient has been in ICU for more than 5 days.

  3. Patient has suspected or proven primary myopathic or neurological process associatedwith prolonged weakness or acute brain injury.

  4. Death is deemed imminent by the treating clinician.

  5. Patient has a documented medical diagnosis of cognitive impairment e.g. dementia.

  6. Patient was unable to mobilise prior to this admission.

  7. Patient is unable to communicate in local language.

  8. Patient is known to be pregnant.

  9. Patient is unlikely to be contactable for 6 months follow-up, e.g. overseasresident, incarcerated

  10. The treating clinician does not believe it is in the best interests of the patientto participate in the study

  11. Patient who has a bidirectional cannula in situ

Study Design

Total Participants: 100
Treatment Group(s): 1
Primary Treatment: Early Rehabilitation
Phase:
Study Start date:
April 27, 2022
Estimated Completion Date:
May 30, 2025

Study Description

The trial is a 100-patient, multicentre, randomised, controlled, parallel-group, two-sided superiority trial that will randomly allocate eligible patients to early rehabilitation or standard care in a 1:1 ratio to determine if early rehabilitation of critically ill patients receiving ECMO reduces disability when compared with standard care. ECMO-Rehab trial is a registry embedded trial and will be utilising EXCEL data.

Connect with a study center

  • Royal Prince Alfred Hospital

    Camperdown, New South Wales
    Australia

    Site Not Available

  • St Vincent's Hospital Sydney

    Darlinghurst, New South Wales 2010
    Australia

    Site Not Available

  • The Prince Charles Hospital

    Chermside, Queensland 4032
    Australia

    Site Not Available

  • Princess Alexandra Hospital

    Woolloongabba, Queensland
    Australia

    Site Not Available

  • Alfred Health

    Melbourne, Victoria 3004
    Australia

    Site Not Available

  • Fiona Stanley Hospital

    Murdoch, Western Australia
    Australia

    Site Not Available

  • Toronto General Hospital

    Toronto,
    Canada

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.